Вопросы современной педиатрии (Dec 2014)

THE NATIONAL CONSENSUS PROJECT* «CYSTIC FIBROSIS: DEFINITION, DIAGNOSTIC CRITERIA, AND THERAPY». SECTION «INHALATION THERAPY» (ABRIDGED)

  • Ye. L. Amelina,
  • I. K. Asherova,
  • I. K. Volkov,
  • Т. Ye. Gembitskaya,
  • Ye. K. Ginter,
  • N. А. Il’yenkova,
  • N. I. Kapranov,
  • I. P. Karimova,
  • N. Yu. Kashirskaya,
  • Ye. I. Kondrat’yeva,
  • М. N. Kostyleva,
  • S. А. Krasovsky,
  • N. B. Merzlova,
  • L. P. Nazarenko,
  • L. S. Namazova-Baranova,
  • А. F. Neretina,
  • V. S. Nikonova,
  • А. V. Orlov,
  • S. S. Postnikov,
  • Т. А. Protasova,
  • S. Yu. Semykin,
  • D. F. Sergienko,
  • О. I. Simonova,
  • I. D. Uspenskaya,
  • М. Yu. Chernukha,
  • L. А. Shabalova,
  • I. А. Shaginyan,
  • V. D. Sherman

DOI
https://doi.org/10.15690/vsp.v13i6.1209
Journal volume & issue
Vol. 13, no. 6
pp. 89 – 95

Abstract

Read online

The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including glucocorticoids, recommended for use in cystic fibrosis patients of all age groups in the territory of the Russian Federation

Keywords